Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C32H38N2O8 |
| Molecular Weight | 578.6527 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=CC(OC)=CC=C45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)COC6=CC=C(OC)C=C6
InChI
InChIKey=KFDDPVMIQMFHBI-JLIPXIIDSA-N
InChI=1S/C32H38N2O8/c1-37-19-5-7-20(8-6-19)41-17-28(35)42-27-13-18-16-34-12-11-23-22-10-9-21(38-2)14-25(22)33-30(23)26(34)15-24(18)29(31(27)39-3)32(36)40-4/h5-10,14,18,24,26-27,29,31,33H,11-13,15-17H2,1-4H3/t18-,24+,26-,27-,29+,31+/m1/s1
| Molecular Formula | C32H38N2O8 |
| Molecular Weight | 578.6527 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14336535
Curator's Comment: Mefeserpine (Methoxyphenoserpine) has a weak central depressive effect.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [THE USE OF METHOXYPHENOSERPINE, A RESERPINE DERIVATIVE, IN THE TREATMENT OF HYPERTENSIVE DISEASE]. | 1965-03 |
|
| [CLINICAL EVALUATION OF METHOXYPHENOSERPINE, A SYNTHETIC DERIVATIVE OF RESERPINE]. | 1965 |
|
| THE INFLUENCE OF A NEW RESERPINE DERIVATIVE, METHOXYPHENOSERPINE, ON EXPERIMENTAL ULCERS AND GASTRIC SECRETION IN RATS. | 1964-05 |
|
| [HYPOTENSIVE AND SIDE-EFFECTS OF METHOXYPHENOSERPINE, A NEW RESERPINE DERIVATIVE]. | 1963-11-15 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14336535
Curator's Comment: Humans: most common therapeutically effective dose is that of 7-12 mg. Decreasing of the blood pressure appears after 3 or sometimes even 6 weeks since the beginning of the treatment. https://www.ncbi.nlm.nih.gov/pubmed/14332286
Rats: The dose of 25.0 mg/kg causing the comparable increase of the concentration of pepsin in the gastric juice of normal rats is 5 times higher than that of reserpine.
Route of Administration:
Intraperitoneal
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:36:18 GMT 2025
by
admin
on
Mon Mar 31 18:36:18 GMT 2025
|
| Record UNII |
42EL4L295A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C270
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3045407
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105820
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
SUB08707MIG
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
3735-85-1
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
100000081440
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
C87628
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
42EL4L295A
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
DTXSID0046721
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
1792
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |